ACE, angiotensin I converting enzyme, 1636

N. diseases: 1082; N. variants: 82
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
5,10-Methylenetetrahydrofolate reductase deficiency
0.010 Biomarker disease BEFREE In contrast, we found synergistic role of ACE (DD)*MTHFR (CT) interaction, showing a positive association in total migraine with aura patients as well as female migraine patients with aura when compared with healthy controls. 19081115 2009
CUI: C1860224
Disease: ABLEPHARON-MACROSTOMIA SYNDROME
ABLEPHARON-MACROSTOMIA SYNDROME
0.040 GeneticVariation disease BEFREE We conclude that I/D-ACE gene polymorphism has no important effect on susceptibility to AMS or HAPE. 12471298 2002
CUI: C1860224
Disease: ABLEPHARON-MACROSTOMIA SYNDROME
ABLEPHARON-MACROSTOMIA SYNDROME
0.040 GeneticVariation disease BEFREE Our results revealed no significant differences in risk for AMS between carriers of ACE deletion and insertion polymorphism alleles. 23270441 2012
CUI: C1860224
Disease: ABLEPHARON-MACROSTOMIA SYNDROME
ABLEPHARON-MACROSTOMIA SYNDROME
0.040 GeneticVariation disease BEFREE ACE (I/D) was significantly associated with HR in CMS patients while the AGT M235T was significantly associated with SaO(2) and BPs/d in AMS patients. 20570668 2010
CUI: C1860224
Disease: ABLEPHARON-MACROSTOMIA SYNDROME
ABLEPHARON-MACROSTOMIA SYNDROME
0.040 GeneticVariation disease BEFREE Thus, ACE I/D genotype is associated with successful high altitude ascent in this prospective study-an association not explicable by genotype-dependence of AMS onset or severity. 15578201 2005
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.080 GeneticVariation phenotype BEFREE SZ and BD characterized by similar or different gene variant in ACE could be a useful marker for these psychiatric disorders, if this polymorphism is replicated in the future studies. 20010451 2010
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.080 Biomarker phenotype BEFREE A number of factors make the angiotensin-converting enzyme (ACE) a candidate gene for psychiatric disorders, including its action on neurotransmitters such as dopamine. 18986708 2009
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.080 Biomarker phenotype BEFREE The Addenbrooke's Cognitive Examination III (ACE-III), an adaptation of the ACE cognitive screening test, has been demonstrated to have high sensitivity and specificity in detecting cognitive impairment in patients with dementia and other neurological and psychiatric disorders. 28865943 2017
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.080 Biomarker phenotype BEFREE Angiotensin converting enzyme (ACE) is a candidate gene for psychiatric disorders. 11920854 2002
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.080 Biomarker phenotype BEFREE Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors. 30185634 2018
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.080 Biomarker phenotype BEFREE Using structural equation modelling, ACE models assuming additive genetic (A), shared environmental (C) and unique environmental (E) influences, were compared in order to examine whether the contribution of genetic factors to parent-rated child problem behaviour varied as a function of exposure to dichotomously and continuously defined PBCs. 12420886 2002
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.080 GeneticVariation phenotype BEFREE The angiotensin converting enzyme (ACE) gene, which has been found to have an insertion and deletion polymorphism (I/D), is of increasing interest in etiology and treatment of various psychiatric disorders such as panic disorder. 25189904 2015
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.080 Biomarker phenotype BEFREE Several lines of evidence support the interaction between brain angiotensins and central catecholamine systems, and suggest that angiotensin I-converting enzyme (ACE) may be a reasonable candidate gene for psychiatric disorders. 16236416 2006
CUI: C4021821
Disease: Abnormality of the urinary system
Abnormality of the urinary system
0.100 Biomarker disease HPO
CUI: C0702166
Disease: Acne
Acne
0.010 GeneticVariation disease BEFREE The aim of this work was to reveal the relation between the ACE gene I/D polymorphism and acne vulgaris development among a sample of patients. 31033180 2019
CUI: C0001144
Disease: Acne Vulgaris
Acne Vulgaris
0.010 GeneticVariation disease BEFREE The aim of this work was to reveal the relation between the ACE gene I/D polymorphism and acne vulgaris development among a sample of patients. 31033180 2019
CUI: C2931758
Disease: Acquired angioedema
Acquired angioedema
0.020 Biomarker disease BEFREE As a trigger of AAE in the present patient, we revealed primary antiphospholipid syndrome accompanied by antithrombin III deficiency, along with malignancy in the history, and angiotensin-converting enzyme inhibitor therapy. 18204284 2008
CUI: C2931758
Disease: Acquired angioedema
Acquired angioedema
0.020 GeneticVariation disease BEFREE According to this classification, three types of hereditary angioedema (genetic C1-INH deficiency, normal C1-INH with factor XII mutations, and unknown origin) and four types of acquired angioedema (C1-INH deficiency, related to ACE inhibitors intake, idiopathic histaminergic, and idiopathic non-histaminergic) are presented. 27113957 2016
CUI: C0001206
Disease: Acromegaly
Acromegaly
0.020 GeneticVariation disease BEFREE The aim of the study was to investigate the association between ACE (I/D) and AGT (M235T) gene polymorphisms and cardiovascular and metabolic disorders in the acromegaly. 28712073 2017
CUI: C0001206
Disease: Acromegaly
Acromegaly
0.020 GeneticVariation disease BEFREE Effects of angiotensin-converting enzyme gene polymorphism on the left-ventricular function and mass in patients with acromegaly. 10844381 1999
CUI: C0600433
Disease: Activated Protein C Resistance
Activated Protein C Resistance
0.010 Biomarker disease BEFREE The magnitudes of stroke risk observed for factor V Leiden, ACE, MTHFR and prothrombin, but not PAI-1, polymorphisms, are consistent with risks associated with equivalent changes in activated protein C resistance, ACE activity, homocysteine, prothrombin, and PAI-1 levels, respectively. 20161734 2010
Acute Anterior Wall Myocardial Infarction
0.030 GeneticVariation disease BEFREE Influence of angiotensin-converting enzyme I/D gene polymorphism on the right ventricular myocardial performance index in patients with a first acute anterior myocardial infarction. 15671615 2005
Acute Anterior Wall Myocardial Infarction
0.030 GeneticVariation disease BEFREE This exploratory study suggests that homozygosity for the angiotensin-converting enzyme deletion-type allele is associated with augmented neurohumoral activation as well as augmented cardiac dilation after an acute anterior myocardial infarction, an effect that may be susceptible to angiotensin-converting enzyme inhibition. 7759715 1995
Acute Anterior Wall Myocardial Infarction
0.030 GeneticVariation disease BEFREE Sixty four patients (11 women and 53 men), aged 25 to 77 years, with AAMI were studied.The ACE genotypes were established. 17235107 2007
CUI: C0241868
Disease: acute aortic dissection
acute aortic dissection
0.010 GeneticVariation disease BEFREE The deletion polymorphism of the angiotensin-converting enzyme gene is associated with acute aortic dissection. 19713682 2009